Serge Belanger
Stock Analyst at Needham
(4.61)
# 194
Out of 5,090 analysts
374
Total ratings
55.49%
Success rate
24.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals | Reiterates: Buy | $28 | $16.43 | +70.42% | 22 | Dec 4, 2025 | |
| CRMD CorMedix | Maintains: Buy | $20 → $16 | $10.56 | +51.52% | 19 | Nov 12, 2025 | |
| OCS Oculis Holding AG | Reiterates: Buy | $36 | $21.68 | +66.05% | 2 | Nov 11, 2025 | |
| AMPH Amphastar Pharmaceuticals | Maintains: Buy | $36 → $34 | $26.77 | +27.01% | 8 | Nov 7, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Buy | $40 → $46 | $35.26 | +30.46% | 10 | Nov 5, 2025 | |
| BCRX BioCryst Pharmaceuticals | Maintains: Buy | $20 → $18 | $7.59 | +137.15% | 18 | Nov 4, 2025 | |
| LQDA Liquidia | Maintains: Buy | $36 → $52 | $34.41 | +51.12% | 34 | Nov 4, 2025 | |
| XENE Xenon Pharmaceuticals | Reiterates: Buy | $55 | $45.01 | +22.20% | 13 | Nov 4, 2025 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $22 → $30 | $31.20 | -3.85% | 23 | Oct 28, 2025 | |
| COLL Collegium Pharmaceutical | Reiterates: Buy | $46 | $47.91 | -3.99% | 26 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $10.85 | - | 9 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $12.58 | +58.98% | 5 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $20 | $14.90 | +34.23% | 14 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $72 | $65.67 | +9.64% | 24 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.31 | +129.01% | 23 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $22 | $13.47 | +63.33% | 22 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $34 | $32.02 | +6.18% | 18 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $22 | $6.85 | +221.17% | 16 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $8.81 | - | 19 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $30 | $23.99 | +25.05% | 28 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $3.73 | +7.24% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.54 | - | 1 | Mar 31, 2022 |
KalVista Pharmaceuticals
Dec 4, 2025
Reiterates: Buy
Price Target: $28
Current: $16.43
Upside: +70.42%
CorMedix
Nov 12, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $10.56
Upside: +51.52%
Oculis Holding AG
Nov 11, 2025
Reiterates: Buy
Price Target: $36
Current: $21.68
Upside: +66.05%
Amphastar Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $36 → $34
Current: $26.77
Upside: +27.01%
NewAmsterdam Pharma Company
Nov 5, 2025
Maintains: Buy
Price Target: $40 → $46
Current: $35.26
Upside: +30.46%
BioCryst Pharmaceuticals
Nov 4, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $7.59
Upside: +137.15%
Liquidia
Nov 4, 2025
Maintains: Buy
Price Target: $36 → $52
Current: $34.41
Upside: +51.12%
Xenon Pharmaceuticals
Nov 4, 2025
Reiterates: Buy
Price Target: $55
Current: $45.01
Upside: +22.20%
Arcutis Biotherapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $22 → $30
Current: $31.20
Upside: -3.85%
Collegium Pharmaceutical
Oct 28, 2025
Reiterates: Buy
Price Target: $46
Current: $47.91
Upside: -3.99%
Oct 15, 2025
Reiterates: Hold
Price Target: n/a
Current: $10.85
Upside: -
Oct 1, 2025
Maintains: Buy
Price Target: $15 → $20
Current: $12.58
Upside: +58.98%
Sep 30, 2025
Maintains: Buy
Price Target: $66 → $20
Current: $14.90
Upside: +34.23%
Sep 2, 2025
Reiterates: Buy
Price Target: $72
Current: $65.67
Upside: +9.64%
Aug 8, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.31
Upside: +129.01%
Aug 8, 2025
Maintains: Buy
Price Target: $24 → $22
Current: $13.47
Upside: +63.33%
Aug 6, 2025
Maintains: Buy
Price Target: $36 → $34
Current: $32.02
Upside: +6.18%
Aug 6, 2025
Downgrades: Hold
Price Target: $22
Current: $6.85
Upside: +221.17%
May 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $8.81
Upside: -
May 9, 2025
Maintains: Buy
Price Target: $32 → $30
Current: $23.99
Upside: +25.05%
May 7, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $3.73
Upside: +7.24%
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.54
Upside: -